Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025

Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-01

Pages: 80 Pages

Report ld: 3445408

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Attention Deficit and Hyperactivity Disorder was valued at US$ 20500 million in the year 2024 and is projected to reach a revised size of US$ 32710 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Attention deficit hyperactivity disorder (ADHD) is a condition that affects people"s behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.

The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.

This report aims to provide a comprehensive presentation of the global market for Attention Deficit and Hyperactivity Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit and Hyperactivity Disorder.

The Attention Deficit and Hyperactivity Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Attention Deficit and Hyperactivity Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Attention Deficit and Hyperactivity Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Stimulant
Non-stimulant

Segment by Application

Hospital
Retail Pharmacy
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Attention Deficit and Hyperactivity Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Stimulant

1.2.3 Non-stimulant

1.3 Market by Application

1.3.1 Global Attention Deficit and Hyperactivity Disorder Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Attention Deficit and Hyperactivity Disorder Market Perspective (2020-2031)

2.2 Global Attention Deficit and Hyperactivity Disorder Growth Trends by Region

2.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Attention Deficit and Hyperactivity Disorder Historic Market Size by Region (2020-2025)

2.2.3 Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2026-2031)

2.3 Attention Deficit and Hyperactivity Disorder Market Dynamics

2.3.1 Attention Deficit and Hyperactivity Disorder Industry Trends

2.3.2 Attention Deficit and Hyperactivity Disorder Market Drivers

2.3.3 Attention Deficit and Hyperactivity Disorder Market Challenges

2.3.4 Attention Deficit and Hyperactivity Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue

3.1.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue (2020-2025)

3.1.2 Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Players (2020-2025)

3.2 Global Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Attention Deficit and Hyperactivity Disorder Revenue

3.4 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio

3.4.1 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit and Hyperactivity Disorder Revenue in 2024

3.5 Global Key Players of Attention Deficit and Hyperactivity Disorder Head office and Area Served

3.6 Global Key Players of Attention Deficit and Hyperactivity Disorder, Product and Application

3.7 Global Key Players of Attention Deficit and Hyperactivity Disorder, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Attention Deficit and Hyperactivity Disorder Breakdown Data by Type

4.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Type (2020-2025)

4.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2026-2031)

5 Attention Deficit and Hyperactivity Disorder Breakdown Data by Application

5.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Application (2020-2025)

5.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

6.2 North America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

6.4 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

7.2 Europe Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

7.4 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

8.2 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025)

8.4 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

9.2 Latin America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

9.4 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

10.2 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

10.4 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Attention Deficit and Hyperactivity Disorder Introduction

11.1.4 Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.1.5 Takeda Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Attention Deficit and Hyperactivity Disorder Introduction

11.2.4 Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Attention Deficit and Hyperactivity Disorder Introduction

11.3.4 Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Attention Deficit and Hyperactivity Disorder Introduction

11.4.4 Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.4.5 Eli Lilly Recent Development

11.5 Tris Pharma

11.5.1 Tris Pharma Company Details

11.5.2 Tris Pharma Business Overview

11.5.3 Tris Pharma Attention Deficit and Hyperactivity Disorder Introduction

11.5.4 Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.5.5 Tris Pharma Recent Development

11.6 Neos Therapeutics

11.6.1 Neos Therapeutics Company Details

11.6.2 Neos Therapeutics Business Overview

11.6.3 Neos Therapeutics Attention Deficit and Hyperactivity Disorder Introduction

11.6.4 Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.6.5 Neos Therapeutics Recent Development

11.7 Mallinckrodt

11.7.1 Mallinckrodt Company Details

11.7.2 Mallinckrodt Business Overview

11.7.3 Mallinckrodt Attention Deficit and Hyperactivity Disorder Introduction

11.7.4 Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.7.5 Mallinckrodt Recent Development

11.8 Amneal Pharmaceuticals

11.8.1 Amneal Pharmaceuticals Company Details

11.8.2 Amneal Pharmaceuticals Business Overview

11.8.3 Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction

11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.8.5 Amneal Pharmaceuticals Recent Development

11.9 Noven Pharmaceuticals

11.9.1 Noven Pharmaceuticals Company Details

11.9.2 Noven Pharmaceuticals Business Overview

11.9.3 Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction

11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.9.5 Noven Pharmaceuticals Recent Development

11.10 Purdue Parma

11.10.1 Purdue Parma Company Details

11.10.2 Purdue Parma Business Overview

11.10.3 Purdue Parma Attention Deficit and Hyperactivity Disorder Introduction

11.10.4 Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.10.5 Purdue Parma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Stimulant

Table 3. Key Players of Non-stimulant

Table 4. Global Attention Deficit and Hyperactivity Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2020-2025)

Table 8. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2026-2031)

Table 10. Attention Deficit and Hyperactivity Disorder Market Trends

Table 11. Attention Deficit and Hyperactivity Disorder Market Drivers

Table 12. Attention Deficit and Hyperactivity Disorder Market Challenges

Table 13. Attention Deficit and Hyperactivity Disorder Market Restraints

Table 14. Global Attention Deficit and Hyperactivity Disorder Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Attention Deficit and Hyperactivity Disorder Market Share by Players (2020-2025)

Table 16. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2024)

Table 17. Ranking of Global Top Attention Deficit and Hyperactivity Disorder Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Attention Deficit and Hyperactivity Disorder, Headquarters and Area Served

Table 20. Global Key Players of Attention Deficit and Hyperactivity Disorder, Product and Application

Table 21. Global Key Players of Attention Deficit and Hyperactivity Disorder, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Attention Deficit and Hyperactivity Disorder Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2020-2025)

Table 25. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2026-2031)

Table 27. Global Attention Deficit and Hyperactivity Disorder Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2020-2025)

Table 29. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2026-2031)

Table 31. North America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 46. Takeda Company Details

Table 47. Takeda Business Overview

Table 48. Takeda Attention Deficit and Hyperactivity Disorder Product

Table 49. Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 50. Takeda Recent Development

Table 51. Johnson & Johnson Company Details

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Attention Deficit and Hyperactivity Disorder Product

Table 54. Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Attention Deficit and Hyperactivity Disorder Product

Table 59. Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Eli Lilly Company Details

Table 62. Eli Lilly Business Overview

Table 63. Eli Lilly Attention Deficit and Hyperactivity Disorder Product

Table 64. Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 65. Eli Lilly Recent Development

Table 66. Tris Pharma Company Details

Table 67. Tris Pharma Business Overview

Table 68. Tris Pharma Attention Deficit and Hyperactivity Disorder Product

Table 69. Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 70. Tris Pharma Recent Development

Table 71. Neos Therapeutics Company Details

Table 72. Neos Therapeutics Business Overview

Table 73. Neos Therapeutics Attention Deficit and Hyperactivity Disorder Product

Table 74. Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 75. Neos Therapeutics Recent Development

Table 76. Mallinckrodt Company Details

Table 77. Mallinckrodt Business Overview

Table 78. Mallinckrodt Attention Deficit and Hyperactivity Disorder Product

Table 79. Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 80. Mallinckrodt Recent Development

Table 81. Amneal Pharmaceuticals Company Details

Table 82. Amneal Pharmaceuticals Business Overview

Table 83. Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product

Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 85. Amneal Pharmaceuticals Recent Development

Table 86. Noven Pharmaceuticals Company Details

Table 87. Noven Pharmaceuticals Business Overview

Table 88. Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product

Table 89. Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 90. Noven Pharmaceuticals Recent Development

Table 91. Purdue Parma Company Details

Table 92. Purdue Parma Business Overview

Table 93. Purdue Parma Attention Deficit and Hyperactivity Disorder Product

Table 94. Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 95. Purdue Parma Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Attention Deficit and Hyperactivity Disorder Picture

Figure 2. Global Attention Deficit and Hyperactivity Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Attention Deficit and Hyperactivity Disorder Market Share by Type: 2024 VS 2031

Figure 4. Stimulant Features

Figure 5. Non-stimulant Features

Figure 6. Global Attention Deficit and Hyperactivity Disorder Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Attention Deficit and Hyperactivity Disorder Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Others Case Studies

Figure 11. Attention Deficit and Hyperactivity Disorder Report Years Considered

Figure 12. Global Attention Deficit and Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Attention Deficit and Hyperactivity Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Attention Deficit and Hyperactivity Disorder Market Share by Region: 2024 VS 2031

Figure 15. Global Attention Deficit and Hyperactivity Disorder Market Share by Players in 2024

Figure 16. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue in 2024

Figure 18. North America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 20. United States Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 24. Germany Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Share by Region (2020-2031)

Figure 32. China Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 40. Mexico Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 44. Turkey Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Takeda Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 48. Johnson & Johnson Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 50. Eli Lilly Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 51. Tris Pharma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 52. Neos Therapeutics Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 53. Mallinckrodt Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 54. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 55. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 56. Purdue Parma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Attention Deficit and Hyperactivity Disorder in 2025? shouQi

Which companies rank high in the global Attention Deficit and Hyperactivity Disorder market? shouQi

What is the annual compound growth rate of the global Attention Deficit and Hyperactivity Disorder market size from 2025 to 2031? shouQi

Related Reports

Global Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2030
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published Date: 2024-04-12
Pages: 105
USD 4900.00
(Single User License)
Global Attention Deficit and Hyperactivity Disorder Market Research Report 2024
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published Date: 2024-01-12
Pages: 80
USD 2900.00
(Single User License)
Attention Deficit and Hyperactivity Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published Date: 2024-01-08
Pages: 109
USD 3950.00
(Single User License)

Global Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2030
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published: 2024-04-12
Pages: 105
USD 4900.00 (Single User License)
Global Attention Deficit and Hyperactivity Disorder Market Research Report 2024
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published: 2024-01-12
Pages: 80
USD 2900.00 (Single User License)
Attention Deficit and Hyperactivity Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published: 2024-01-08
Pages: 109
USD 3950.00 (Single User License)